Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes. (2020). Farmeconomia. Health Economics and Therapeutic Pathways, 21(1S). https://doi.org/10.7175/fe.v21i1S.1490